BIOLASE, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2009-11-30: Form 8-K; Period of report 2009-11-30; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2009-11-05: Form 8-K; Period of report 2009-11-05; Description 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 2.02.
- 2009-10-27: Form 8-K; Period of report 2009-10-21; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2009-09-30: Form 8-K; Period of report 2009-09-24; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2009-11-30 | 8-K | 2009-11-30 | 7.01 Regulation FD Disclosure | 7.01 On June 30, 2009, David M. Mulder, Chief Executive Officer of Biolase Technology, Inc., will deliver a presentation to investors that will include a written communication comprised of slides. | a54479e8vk.htm |
| 2009-11-05 | 8-K | 2009-11-05 | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 2.02 On November 5, 2009, Biolase Technology, Inc. (the "Company") issued a press release announcing its financial results for the third quarter ended September 30, 2009. 5.02 On October 27, 2009, the Company filed a Current Report on Form 8-K to disclose that the Company's Board of Directors (the "Board") elected Gregory D. Waller to the Board. | htm_34996.htm |
| 2009-10-27 | 8-K | 2009-10-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 21, 2009, the Board of Directors (the "Board") of Biolase Technology, Inc. (the "Company") elected Gregory D. Waller, age 59, to the Board of Directors. | htm_34814.htm |
| 2009-09-30 | 8-K | 2009-09-24 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | htm_34510.htm |
| 2009-09-16 | 8-K | 2009-09-10 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | htm_34343.htm |
| 2009-08-10 | 8-K/A | 2009-07-14 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On July 15, 2009, Biolase Technology, Inc. (the "Company") reported on a Current Report on Form 8-K (the "July 15, 2009 Form 8-K") that, effective July 14, 2009, Frederick M. Capallo resigned from his position with the Company. | htm_33870.htm |
| 2009-08-06 | 8-K | 2009-08-06 | 2.02 Results of Operations and Financial Condition | 2.02 On August 6, 2009, Biolase Technology, Inc. issued a press release announcing its financial results for the second quarter and six months ended June 30, 2009. | htm_33816.htm |
| 2009-07-15 | 8-K | 2009-07-14 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 On July 14, 2009, Biolase Technology, Inc. (the "Company") issued a press release announcing that, effective July 14, 2009, it had appointed Brett L. Scott as Chief Financial Officer of the Company. | htm_33488.htm |
| 2009-07-07 | 8-K | 2009-07-07 | 2.02 Results of Operations and Financial Condition | 2.02 On July 7, 2009, Biolase Technology, Inc. (the "Company") issued a press release announcing preliminary financial results for the second quarter ended June 30, 2009. | htm_33411.htm |
| 2009-06-11 | 8-K | 2009-06-11 | 7.01 Regulation FD Disclosure | 7.01 On June 11, 2009, David M. Mulder, Chief Executive Officer of Biolase Technology, Inc., will deliver a presentation at the 8th Annual Needham Life Sciences Conference that will include a written communication comprised of slides. | a52863e8vk.htm |
| 2009-05-07 | 8-K | 2009-05-07 | 2.02 Results of Operations and Financial Condition | 2.02 On May 7, 2009, Biolase Technology, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2009. | htm_32667.htm |
| 2009-04-15 | 8-K/A | 2009-03-23 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On March 26, 2009, Biolase Technology, Inc. (the "Company") filed a Current Report on Form 8-K with the Securities and Exchange Commission (the "March 26, 2009 Form 8-K"), and Amendment No. 1 to the March 26, 2009 Form 8-K, filed on April 8, 2009 (together with the March 26, 2009 Form 8-K, the "NASDAQ Form 8-K") relating to the Company's compliance with the listing standards of The NASDAQ Global Market. | htm_32281.htm |
| 2009-04-09 | 8-K/A | 2009-03-23 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On March 26, 2009, Biolase Technology, Inc. (the "Company") filed a Current Report on Form 8-K with the Securities and Exchange Commission (the "March 26, 2009 Form 8-K") to disclose that on March 23, 2009, the Company received a letter from The NASDAQ Stock Market (the "NASDAQ Letter") indicating that the Company did not comply with the minimum stockholders’ equity requirement for continued listing on The NASDAQ Global Market. | htm_32197.htm |
| 2009-04-09 | 8-K/A | 2009-03-05 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 On March 5, 2009, Biolase Technology, Inc. (the "Company") filed a Current Report on Form 8-K with the Securities and Exchange Commission, which was amended by Amendment No. 1 to the Current Report on Form 8-K, filed on March 13, 2009 (together, the "March Form 8-K") to disclose, among other things, the appointment of David M. Mulder, previously the Company’s Chief Financial Officer, to the position of Chief Executive Officer. | htm_32195.htm |
| 2009-03-26 | 8-K | 2009-03-25 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | htm_31997.htm |
| 2009-03-26 | 8-K | 2009-03-23 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On March 23, 2009, Biolase Technology, Inc. (the "Company") received a staff deficiency letter from The NASDAQ Stock Market indicating that based on the Company’s stockholders’ equity as reported in its Annual Report on Form 10-K for the year ended December 31, 2008, the Company does not comply with the minimum stockholders’ equity requirement of $10 million for continued listing on The NASDAQ Global Market as set forth in NASDAQ Marketplace Rule 4450(a)(3). | htm_31996.htm |
| 2009-03-19 | 8-K/A | 2009-02-27 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The information included in Item 1.01 of this Current Report on Form 8-K regarding the Security Agreement undertaking is incorporated by reference into this Item 2.03. | htm_31878.htm |
| 2009-03-16 | 8-K | 2009-03-16 | 2.02 Results of Operations and Financial Condition | 2.02 On March 16, 2009, Biolase Technology, Inc. (the "Company") issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2008. | htm_31844.htm |
| 2009-03-13 | 8-K/A | 2009-03-05 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 5, 2009, Biolase Technology, Inc. (the "Company") filed a Current Report on Form 8-K (the "March 5, 2009 Form 8-K") with the Securities and Exchange Commission to disclose, among other things, the resignation of Jake P. St. Philip from his position as Chief Executive Officer and as a director of the Company. | htm_31817.htm |
| 2009-03-10 | 8-K | 2009-03-10 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 10, 2009, Biolase Technology, Inc. (the "Company") issued a press release announcing that it had appointed Frederick M. Capallo as interim Chief Financial Officer of the Company. | htm_31744.htm |
| 2009-03-05 | 8-K | 2009-03-04 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 On March 5, 2009, Biolase Technology, Inc. (the "Company") issued a press release announcing that, effective as of March 5, 2009, Jake P. St. Philip resigned from his position as Chief Executive Officer and resigned as a director of the Company, effective as of the same date. | htm_31675.htm |
| 2009-03-05 | 8-K | 2009-02-27 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The information included in Item 1.01 of this Current Report on Form 8-K regarding the Security Agreement undertaking is incorporated by reference into this Item 2.03. | htm_31672.htm |
| 2009-02-05 | 8-K | 2009-01-30 | 1.02 Termination of a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 8.01 Other Events | 1.02 On February 5, 2009, Biolase Technology, Inc. (the "Company") terminated its Loan and Security Agreement (the "Loan Agreement") with Comerica Bank ("Comerica"), dated September 28, 2006. 2.02 On February 5, 2009, the Company issued a press release announcing preliminary revenue figures for the fourth quarter and year ended December 31, 2008. 8.01 On February 5, 2008, the Company issued a press release announcing, among other things, a global work force reduction and operational restructuring designed to reduce the Company's cash breakeven point to sales levels under $50 million. | htm_31246.htm |